NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

矿物质缺乏症:全球临床实验趋势

Mineral Deficiency Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品编码 602482
出版日期 内容资讯 英文 60 Pages
订单完成后即时交付
价格
矿物质缺乏症:全球临床实验趋势 Mineral Deficiency Global Clinical Trials Review, H2, 2017
出版日期: 2017年12月28日内容资讯: 英文 60 Pages
简介

本报告提供矿物质缺乏症治疗药临床实验相关的基本数据和资料,汇整实验数量及受验者的募集情况,各阶段趋势,实施临床实验的主要制药企业及研究机关的简介等资料。

本报告概要

调查范围

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 亚太地区主要5国的临床实验数量
    • 欧洲主要5国的临床实验数量
    • 北美主要国家的临床实验数量
    • 中东·非洲主要国家的临床实验数量
    • 中南美主要国家的临床实验数量

G7各国临床实验数量:营养障碍治疗药临床实验上矿物质缺乏症的比例

G7各国的各阶段临床实验数量

G7各国临床实验数量:各进展状况

E7各国临床实验数量:营养障碍治疗药临床实验上矿物质缺乏症的比例

E7各国的各阶段临床实验数量

E7各国临床实验数量:各进展状况

各阶段临床实验数量

  • 进行中的临床实验:各阶段

各进展状况临床实验数量

临床实验的目标达成情形

一定期间所采用的实验对象

赞助商类别的临床实验数量

有潜力的赞助商

矿物质缺乏症治疗药临床实验主要的参与企业

有潜力的药剂

临床实验简介概要

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC4797CTIDB

GlobalData's clinical trial report, "Mineral Deficiency Global Clinical Trials Review, H2, 2017" provides an overview of Mineral Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Mineral Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Mineral Deficiency to Nutritional Disorders Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Mineral Deficiency to Nutritional Disorders Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Mineral Deficiency Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29
  • Appendix 58
  • Abbreviations 58
  • Definitions 58
  • Research Methodology 59
  • Secondary Research 59
  • About GlobalData 60
  • Contact Us 60
  • Source 60

List of Tables

  • Mineral Deficiency Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Mineral Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Mineral Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Mineral Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Mineral Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Mineral Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Mineral Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Mineral Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Mineral Deficiency to Nutritional Disorders Clinical Trials, G7 Countries (%), 2017* 14
  • Mineral Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Mineral Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Mineral Deficiency to Nutritional Disorders Clinical Trials, E7 Countries (%), 2017* 17
  • Mineral Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Mineral Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Mineral Deficiency Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Mineral Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Mineral Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Mineral Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Mineral Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Mineral Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Mineral Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Mineral Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Mineral Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28